General Surgery · Evidence depth: moderate

Breast Surgery

Moderate to high.

Ownership-sensitivity model

The 10 vectors of a physician career.

Every path is scored 0-100 across 10 critical dimensions using public-data signals, modeled assumptions, and verification prompts. Modeled estimate. Not a salary survey. See methodology.

65/100

Income ceiling

Income ceiling

Solid and highly reliable, but features lower RVU density than GI or Ortho.

The reality

Income is heavily dependent on whether you can secure ASC ownership to capture facility fees for lumpectomies and mastectomies.

The signal

Many breast surgeons are directly employed by massive hospital cancer centers, which strictly caps financial upside.

The catch

Provides a very comfortable living, but very rarely reaches the top-decile wealth of spine or interventional cardiology.

The verdict

Most surgeons in this field consider the lifestyle and emotional rewards well worth the income trade-off.

85/100

Lifestyle control

Lifestyle control

Excellent, offering one of the best schedules in the general surgery tree.

The reality

The practice is 100% elective and scheduled; breast cancer never requires emergency surgery at 3 AM.

The signal

You have immense power to control the pace of your clinic, your OR days, and your overall week.

The catch

The primary stressor in this field is the emotional burden of oncology, absolutely not the schedule.

The verdict

An elite option for those who want to be surgeons but also want a highly predictable family life.

Premium analysis

8 more dimensions scored, with the reasoning behind each

See plans and unlock

The scores are below. Premium adds what sits behind each one: the claim, the signal supporting it, the limitation that weakens it, and what it should change about your decision.

  • Sleep / call burdenLower is better15/100
  • Ownership / facility upsideHigher is better50/100
  • Geography flexibilityHigher is better65/100
  • Innovation / industry adjacencyHigher is better30/100
  • Training opportunity costLower is better40/100
  • Job-market densityHigher is better70/100
  • Malpractice / litigation pressureLower is better40/100
  • Burnout-mismatch riskLower is better30/100

Scores are modeled from the specialty module's evidence and are estimates, not measurements. Confidence and data depth are labeled inside every premium card.

DoctorCalculator modeled income structure

Derived model. Directional

Modeled base range

$405k - $515k

Clinic-heavy, lifestyle-favorable; below the GS average.

Production upside

Moderate–high

Clinic-dominant with predictable OR blocks; lifestyle-favorable at the cost of production ceiling.

Ownership upside

Moderate

Modest: practice ownership with in-office ultrasound/biopsy; most breast surgery is system-employed.

Salary-only gap

Moderate

Small gap. Clinic-heavy elective practice prices similarly employed or private.

Modeled estimate. Not a salary survey. Derived model. Directional only. Verify against real offers, contracts, and local mentors. Income scales with payer mix, ownership, and geography. See methodology.

Want the code-level view behind numbers like these? Open the RVU calculator for this specialty's procedures, CMS times, and locality-adjusted Medicare rates.

External benchmark reference

Verify independently

~$420k

External benchmark reference - verify independently. Not ingested DoctorCalculator source data.

Hospital-employedPrivate groupAcademic

Best fit

  • The Lifestyle-First Clinician. A good life on sane hours, and the math actually works.

Poor fit

  • The Acute-Care Identity Seeker. Energized by intensity, emergencies, and high-stakes work.

Premium detail

Common regrets on this path

See plans and unlock

2 documented regrets for this path, each with the burnout driver behind it and the question to verify it against a real schedule before you commit. Written from field notes on this specialty, not generic career advice.

This path is described at validated confidence (Evidence depth: moderate). Detailed evidence cards are added as the module is validated; we will not manufacture precision before then.